Literature DB >> 10373217

Cortisol effects on body mass, blood pressure, and cholesterol in the general population.

R Fraser1, M C Ingram, N H Anderson, C Morrison, E Davies, J M Connell.   

Abstract

The effects of excess cortisol secretion on blood pressure and fat deposition are well documented, but the importance of this glucocorticoid in controlling these processes in normal individuals is less clear. We studied the relationship between cortisol excretion rate (tetrahydrocortisol [THF]+allo-THF+tetrahydrocortisone [THE]) and a range of important cardiovascular risk factors in 439 normal subjects (238 male) sampled from the North of Glasgow (Scotland) population. There were marked gender differences: female subjects were lighter and had lower blood pressures and cortisol levels, whereas HDL cholesterol was higher. The pattern of cortisol metabolism was also different; the index of 11beta-hydroxysteroid dehydrogenase activity (THF+allo-THF/THE) was lower and that of 5alpha-reductase (allo-THF/THF) was higher. There was a strong correlation of blood pressure (positive), cholesterol (positive), and HDL cholesterol (negative in women, positive in men) with age. Cortisol excretion rate did not correlate with blood pressure but correlated strongly with parameters of body habitus (body mass index and waist and hip measurements [positive]) and HDL cholesterol (negative). With multiple regression analysis, there remained a significant association of cortisol excretion rate with HDL cholesterol in men and women and with body mass index in men. These results suggest that glucocorticoids regulate key components of cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10373217     DOI: 10.1161/01.hyp.33.6.1364

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  75 in total

Review 1.  Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity.

Authors:  Deborah J Wake; Brian R Walker
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Social stratification and adolescent overweight in the United States: how income and educational resources matter across families and schools.

Authors:  Molly A Martin; Michelle L Frisco; Claudia Nau; Kristin Burnett
Journal:  Soc Sci Med       Date:  2011-12-13       Impact factor: 4.634

Review 3.  Cortisol dysregulation in obesity-related metabolic disorders.

Authors:  Rene Baudrand; Anand Vaidya
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

Review 4.  The overtraining syndrome in athletes: a stress-related disorder.

Authors:  A Angeli; M Minetto; A Dovio; P Paccotti
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

5.  G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.

Authors:  Ibolya Czegle; Miklós Csala; József Mandl; Angelo Benedetti; István Karádi; Gábor Bánhegyi
Journal:  World J Hepatol       Date:  2012-04-27

Review 6.  Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

Authors:  Eliza B Geer; Julie Islam; Christoph Buettner
Journal:  Endocrinol Metab Clin North Am       Date:  2014-03       Impact factor: 4.741

7.  Influence of Negative Life Events and Widowhood on Risk for Dementia.

Authors:  Lotte Gerritsen; Hui-Xin Wang; Chandra A Reynolds; Laura Fratiglioni; Margaret Gatz; Nancy L Pedersen
Journal:  Am J Geriatr Psychiatry       Date:  2017-03-16       Impact factor: 4.105

8.  Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

Authors:  P C Souverein; A Berard; T P Van Staa; C Cooper; A C G Egberts; H G M Leufkens; B R Walker
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

9.  Correlation between cortisol and components of the metabolic syndrome in obese children and adolescents.

Authors:  C Guzzetti; S Pilia; A Ibba; S Loche
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

Review 10.  11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.

Authors:  T M Stulnig; W Waldhäusl
Journal:  Diabetologia       Date:  2003-12-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.